Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,307 | -16,797 | -11,906 | -8,046 | -2,918 |
| Depreciation Amortization | 94 | 380 | 288 | 194 | 98 |
| Accounts receivable | -219 | -106 | -142 | -64 | -5 |
| Accounts payable and accrued liabilities | 241 | 967 | 485 | 966 | 1,660 |
| Other Working Capital | -645 | -653 | -1,670 | -2,288 | 375 |
| Other Operating Activity | 1,589 | 119 | 133 | -885 | -2,271 |
| Operating Cash Flow | $-5,246 | $-16,089 | $-12,813 | $-10,122 | $-3,061 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -35 | -8 | -6 | -4 |
| Sale Of Investment | N/A | 1 | 1 | N/A | N/A |
| Investing Cash Flow | $N/A | $-33 | $-6 | $-6 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 17,103 | 11,071 | 11,155 | 11,233 |
| Common Stock Repurchased | -9 | 4,154 | 60 | 60 | 29 |
| Other Financing Activity | -797 | -3,310 | -2,147 | -2,064 | -1,543 |
| Financing Cash Flow | $-806 | $17,946 | $8,984 | $9,151 | $9,719 |
| Exchange Rate Effect | -9 | 134 | 339 | 333 | 558 |
| Beginning Cash Position | 22,183 | 20,454 | 20,368 | 20,522 | 20,666 |
| End Cash Position | 16,122 | 22,413 | 16,872 | 19,877 | 27,878 |
| Net Cash Flow | $-6,061 | $1,958 | $-3,496 | $-644 | $7,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,246 | -16,089 | -12,813 | -10,122 | -3,061 |
| Capital Expenditure | N/A | -35 | -8 | -6 | -4 |
| Free Cash Flow | -5,246 | -16,123 | -12,821 | -10,128 | -3,064 |